To hear about similar clinical trials, please enter your email below
Trial Title:
Early Diagnosis of Malignant Transformation of Pigmentary Skin Lesions
NCT ID:
NCT01167998
Condition:
Malignant Melanoma
Pigmented Nevi
Skin Neoplasm
Conditions: Official terms:
Melanoma
Skin Neoplasms
Nevus, Pigmented
Study type:
Observational
Overall status:
Unknown status
Study design:
Time perspective:
Prospective
Summary:
Malignant Melanoma is a deadly skin cancer that can be cured if diagnosed early. To date
atypical pigmented skin lesions are diagnosed by appearance alone and many moles and
lesions are excised unnecessarily and on the other hand malignant lesions are missed and
diagnosed too late. In this study a protein conjugated to a florescent dye is spread on a
suspicious pigmented lesion, the hypothesis is that this protein binds to malignant cells
only and thus with a special camera that picks up the dye we can find pigmented lesions
with early malignant transformation.
Criteria for eligibility:
Study pop:
Healthy individuals above 18 years of age with pignented skin lesions indicated for
excision
Sampling method:
Non-Probability Sample
Criteria:
Inclusion Criteria:
- pigmented lesion indicated for surgical excision
- over 18 years of age
Exclusion Criteria:
- pregnancy
Gender:
All
Minimum age:
18 Years
Maximum age:
N/A
Healthy volunteers:
Accepts Healthy Volunteers
Locations:
Facility:
Name:
: Hadassah Medical Organization,
Address:
City:
Jerusalem
Zip:
91120
Country:
Israel
Start date:
July 2010
Completion date:
December 2019
Lead sponsor:
Agency:
Hadassah Medical Organization
Agency class:
Other
Source:
Hadassah Medical Organization
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT01167998
